Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The British fine chemical maker Sterling Pharma Solutions will begin producing hydroxychloroquine, a malaria treatment under investigation for COVID-19, at its plant in Newcastle-upon-Tyne, England. Sterling will supply Accord Healthcare, which aims to make up to 50 million hydroxychloroquine tablets a month in Barnstaple, England. The partnership will establish UK supply of hydroxychloroquine, according to Sterling. Last month, Albany Molecular Research announced plans to increase hydroxychloroquine production in Rensselaer, New York.
This article has been sent to the following recipient: